Kenvue Inc.

KVUE

Find Out if You Qualify for a Financial Reward by filling out the form below.

Lead Plaintiff Deadline:
December 08, 2023

Days Left:
-367

calendar

Kenvue Inc. Form












Stock Fraud Law Center does not share your information with others. There is no cost or obligation for you to submit.

Allegations

The filed complaint alleges that defendants made false statements and/or concealed that: (1) Kenvue faces potential headwinds as a result of confirmed concerns about the efficacy of phenylephrine, which it knew or should have known; (2) Kenvue did not discuss risks relating to the efficacy of phenylephrine (or “PE”) in its IPO, the utility of which had been questioned since at least 2007; (3) while the Company disclosed risks relating to litigation, it did not disclose specific risk relating to potential litigation arising from adverse findings on the efficacy of phenylephrine; and (4) as a result, defendants’ public statements were materially false and misleading at all relevant times and negligently prepared.

Eligibility

In order to be included in the lawsuit, you must have incurred a loss on shares of Kenvue purchased or acquired during the class period listed above.

Lead Plaintiff Deadline

If you suffered a loss in Kenvue during the relevant time frame, you have until December 08, 2023 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Active Cases

Ticker Symbol Company Name Join Deadline Join
UPS United Parcel Service, Inc. December 09, 2024 Join
EW Edwards Lifesciences Corporation December 13, 2024 Join
TD The Toronto-Dominion Bank December 23, 2024 Join
WOLF Wolfspeed, Inc. January 17, 2025 Join